Pricing Log in Create free account

Calidi Biotherapeutics, Inc. (CLDI) vs Revelation Biosciences, Inc. (REVB)

Calidi Biotherapeutics, Inc. and Revelation Biosciences, Inc. are both Biotechnology companies. Calidi Biotherapeutics, Inc. and Revelation Biosciences, Inc. are of similar size ($3.2M and $3.0M). Across the 10 metrics below, Revelation Biosciences, Inc. leads on 8 and Calidi Biotherapeutics, Inc. on 2.

Valuation

Metric CLDI REVB Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.38 0.18 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.07 0.86 0.64
EV/Sales n/m n/m 9.21
Earnings yield (6,464.29%) (2,564.58%) (33.15%)
Free cash flow yield (1,500.29%) (513.59%) (25.50%)

Profitability

Metric CLDI REVB Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (900.56%) (276.43%) (56.36%)
Return on assets (283.36%) (214.63%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLDI REVB Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 83.31% 97.72% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CLDI REVB Biotechnology median
Debt to equity 0.24 0.00 0.00
Current ratio 1.68 6.21 4.72
Net debt to EBITDA 0.26 1.18 0.96

Dividend

Metric CLDI REVB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CLDI REVB Biotechnology median
Market cap 3.20m 3.04m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack